Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

Stress may contribute to the development of hypothyroidism, and both modern and Ayurvedic treatments can manage the condition.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

PPARgamma is crucial for healthy hair follicles, and its loss causes scarring alopecia.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

AMT may cause hair loss and changing dWAT activity could help treat it.

Animal and mathematical models help understand and develop treatments for alopecia areata.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Nivolumab can cause hair loss as a rare side effect.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Obesity is linked to more severe hair loss in adult men and to excess hair growth, but its effects on hair conditions are complex and need more research.

Common hair loss can be diagnosed with a physical exam and sometimes a hair test or skin biopsy, and treated with medication or surgery, with ongoing treatment needed to keep results.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Algal oligosaccharides help prevent hair loss and promote hair growth.

Five molecular elements identified as potential future targets for hair loss therapy.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Infliximab successfully treated a severe hair loss case in Sri Lanka.